Dr Reddys Laboratories Ltd Drl
Opinion  /  Published 31.07.19

Dangerous drugs, compromised regulators

The average consumer of medication in this country does not lose much sleep over drug quality or how drug regulators are doing their job. A new book out in the United States and now available here co...
By Sevanti Ninan

Business  /  Published 27.01.20

Wockhardt back in black

Drug firm Wockhardt has for the first time in three years reported a consolidated net profit of Rs 19.21 crore for the December 2019 quarter mainly on account of an improvement in operational performa...
By PTI in Mumbai

Business  /  Published 10.06.20

Wockhardt, DRL alter deal terms

Wockhardt and Dr Reddy’s Laboratories have recast the terms of their Rs 1,850-crore deal for the sale of the former’s branded generic business because of the Covid-19 impact.In February this year,...
By Our Special Correspondent in Mumbai

Business  /  Published 12.02.20

DRL buys 62 Wockhardt brands, plant

Hyderabad-based Dr Reddy’s Laboratories (DRL) is acquiring a part of the domestic branded business of Wockhardt for Rs 1,850 crore.DRL will acquire the select divisions of Wockhardt’s branded gene...
By Our Special Correspondent in Mumbai

Business  /  Published 14.05.19

Pharmaceutical duo vow to fight price fix charge

Drug majors Aurobindo Pharma and Dr Reddy’s Laboratories on Tuesday said they were preparing their legal defence to the charges of price fixing in the US market.As many as 49 US states have filed pr...
By Our Special Correspondent in Mumbai


Business  /  Published 09.11.18

DRL shares fall after FDA finds flaws

Shares of Hyderabad-based Dr Reddy’s Laboratories Ltd (DRL) on Friday dropped close to two per cent on the bourses over reports the US Food and Drugs Administration (US FDA) has issued eight observa...
By Our Special Correspondent in Mumbai


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.